176 related articles for article (PubMed ID: 10377681)
1. [Interleukin-1 and nitric oxide involved in the pathogenesis of diabetes)].
Sjöholm A
Lakartidningen; 1999 May; 96(19):2338-41. PubMed ID: 10377681
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
Reimers JI
Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of pancreatic beta-cell destruction in autoimmune diabetes: potential targets for preventive therapy.
Iwahashi H; Itoh N; Yamagata K; Imagawa A; Nakajima H; Tomita K; Moriwaki M; Waguri M; Yamamoto K; Miyagawa J; Namba M; Hanafusa T; Matsuzawa Y
Cytokines Cell Mol Ther; 1998 Mar; 4(1):45-51. PubMed ID: 9557216
[TBL] [Abstract][Full Text] [Related]
4. Aspects of the involvement of interleukin-1 and nitric oxide in the pathogenesis of insulin-dependent diabetes mellitus.
Sjöholm A
Cell Death Differ; 1998 Jun; 5(6):461-8. PubMed ID: 10200497
[TBL] [Abstract][Full Text] [Related]
5. beta-Cell death during progression to diabetes.
Mathis D; Vence L; Benoist C
Nature; 2001 Dec; 414(6865):792-8. PubMed ID: 11742411
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of pancreatic beta-cell destruction in type I diabetes.
Nerup J; Mandrup-Poulsen T; Mølvig J; Helqvist S; Wogensen L; Egeberg J
Diabetes Care; 1988; 11 Suppl 1():16-23. PubMed ID: 3069387
[TBL] [Abstract][Full Text] [Related]
7. Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus.
Liadis N; Murakami K; Eweida M; Elford AR; Sheu L; Gaisano HY; Hakem R; Ohashi PS; Woo M
Mol Cell Biol; 2005 May; 25(9):3620-9. PubMed ID: 15831467
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
9. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
Tisch R; Wang B; Serreze DV
J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
[TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanisms of beta-cell destruction in type 1 diabetes].
Mandrup-Poulsen TR
Ugeskr Laeger; 2001 Aug; 163(32):4176-9. PubMed ID: 11510233
[No Abstract] [Full Text] [Related]
11. STAT5 activation by human GH protects insulin-producing cells against interleukin-1beta, interferon-gamma and tumour necrosis factor-alpha-induced apoptosis independent of nitric oxide production.
Jensen J; Galsgaard ED; Karlsen AE; Lee YC; Nielsen JH
J Endocrinol; 2005 Oct; 187(1):25-36. PubMed ID: 16214938
[TBL] [Abstract][Full Text] [Related]
12. Cellular mechanisms involved in experimental insulin-dependent diabetes mellitus.
Radu DL
Roum Arch Microbiol Immunol; 2001; 60(3):203-26. PubMed ID: 12165974
[TBL] [Abstract][Full Text] [Related]
13. [The role of free radicals in pathogenesis of insulin dependent diabetes mellitus].
Komosińska K; Olczyk K
Postepy Hig Med Dosw; 1995; 49(6):733-46. PubMed ID: 8700808
[TBL] [Abstract][Full Text] [Related]
14. Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells.
Yoon JW; Jun HS; Santamaria P
Autoimmunity; 1998; 27(2):109-22. PubMed ID: 9583742
[TBL] [Abstract][Full Text] [Related]
15. The role of the target organ in cytokine-mediated beta-cell destruction. Possible relevance for the pathogenesis of insulin dependent diabetes mellitus.
Andersen HU
Dan Med Bull; 1999 Apr; 46(2):127-64. PubMed ID: 10327296
[No Abstract] [Full Text] [Related]
16. In vitro secretion of interleukin 2 and expression of IL-2 receptor in peripheral blood lymphocytes in high risk of insulin-dependent diabetes mellitus subjects.
Kretowski A; Myśliwiec J; Szelachowska M; Brzozowski C; Pietruczuk M; Kinalska I
Arch Immunol Ther Exp (Warsz); 1999; 47(1):45-9. PubMed ID: 11729828
[TBL] [Abstract][Full Text] [Related]
17. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
18. Death effectors of beta-cell apoptosis in type 1 diabetes.
Lee MS; Chang I; Kim S
Mol Genet Metab; 2004; 83(1-2):82-92. PubMed ID: 15464423
[TBL] [Abstract][Full Text] [Related]
19. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.
Thomas HE; Darwiche R; Corbett JA; Kay TW
J Immunol; 1999 Aug; 163(3):1562-9. PubMed ID: 10415060
[TBL] [Abstract][Full Text] [Related]
20. The possibility that pancreatic beta cell destruction leading to type 1 diabetes is initiated by the release of cytokines by polyclonal activation of the immune system.
Ziegler M; Ziegler B
Exp Clin Endocrinol; 1990 Feb; 95(1):110-8. PubMed ID: 2139848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
